GRCE
NASDAQ · Pharmaceuticals
Grace Therapeutics Inc
$1.87
+0.09 (+5.06%)
Open$1.86
Previous Close$1.78
Day High$1.90
Day Low$1.82
52W High$5.18
52W Low$1.67
Volume—
Avg Volume146.5K
Market Cap38.92M
P/E Ratio—
EPS$-1.18
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,134.8% upside
Current
$1.87
$1.87
Target
$23.09
$23.09
$18.68
$23.09 avg
$33.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.56M | 18.44M | 15.17M |
| Net Income | 2.85M | 2.16M | 2.15M |
| Profit Margin | 14.6% | 11.7% | 14.2% |
| EBITDA | 5.50M | 5.11M | 4.77M |
| Free Cash Flow | 2.45M | 3.17M | 1.86M |
| Rev Growth | +16.3% | +19.0% | +18.1% |
| Debt/Equity | 0.50 | 0.57 | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |